Effect of Melatonin on Pulmonary Hypertension in Full Term Neonates
NCT: NCT07850934 · RECRUITING
Brief Summary
The aim of the study 1. To evaluate safety and efficacy of melatonin as an adjuvant therapy to inhaled nitric oxide generated by NO generator in the treatment of pulmonary hypertension in full term neonates. 2. To assess the effect of inhaled nitric oxide and melatonin on cerebral perfusion.
Frequently Asked Questions
What is Effect of Melatonin on Pulmonary Hypertension in Full Term Neonates?
Effect of Melatonin on Pulmonary Hypertension in Full Term Neonates is a clinical trial registered under NCT07850934. Current status: RECRUITING.
What is the status of NCT07850934?
The current status of NCT07850934 (Effect of Melatonin on Pulmonary Hypertension in Full Term Neonates) is: RECRUITING.
When did Effect of Melatonin on Pulmonary Hypertension in Full Term Neonates start?
Effect of Melatonin on Pulmonary Hypertension in Full Term Neonates started on 2025-07-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.